Team:Freiburg/Highlights/2

From 2013.igem.org

(Difference between revisions)
Line 195: Line 195:
<script src="http://2012.igem-bielefeld.de/includes/wiki/flex/js/jquery.flexslider.js"></script>
<script src="http://2012.igem-bielefeld.de/includes/wiki/flex/js/jquery.flexslider.js"></script>
<!--
<!--
-
<!-- Load the flexslider -->
+
 
-
<script type="text/javascript" charset="utf-8">
+
-
  $(window).load(function() {
+
-
    $('.flexslider').flexslider({
+
-
          animation: "slide",  // slide or fade
+
-
          controlsContainer: ".flex-container" // the container that holds the flexslider
+
-
    });
+
-
  });
+
-
</script> -->
+

Revision as of 10:50, 4 October 2013


HIGHLIGHTS

  • In the last months we were able to ...

    • ... construct a catalytically inactive version of Cas9 and thus generate a DNA binding protein.
    • ... combine this modified dCas9 with different transcriptional effectors.
    • ... express this fusion proteins in various mammalian cell lines.
    • ... control mammalian gene expression via our modified CRISPR/Cas fusion proteins.
    • ... build devices for controling gene expression by light stimulus.
    • ... provide an RNA plasmid for easily inserting sequences for crRNAs which target every desired target.
    • ... build an online tool that generates customized manuals for using our toolkit
    • ... develop a method to assess the DNA binding capacity of our dCas9-fusion proteins.
    • ... make our dCas9 accessible to the whole iGEM community by mutating illegal iGEM restriction sites.
    • ... In summary, we can now offer a universally applicable toolkit for gene regulation.
  • Activation

    Click here to read more about our activation project

  • The Toolbox

    Click here to read more about what the toolbox is and how you can use it.

Retrieved from "http://2013.igem.org/Team:Freiburg/Highlights/2"